Champions Oncology, Inc. SEC filings CSBR
Champions Oncology, Inc. has 655 filings in SEC EDGAR's recent list, going back to Sep 13, 1995. Its latest annual report, Form 10-K, was filed on Jul 27, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 11, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (shareholder vote results). The company's fiscal year ends on April 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Oct 30, 2024 | — |
| 424B4 | Prospectus | Jun 10, 2016 | — |
| S-1/A | Amended registration statement | May 24, 2016 | — |
| S-1 | Registration statement | Apr 26, 2016 | — |
| 424B3 | Prospectus | Oct 15, 2015 | — |
| POS AM | Filing | Sep 25, 2015 | — |
| 424B3 | Prospectus | May 19, 2015 | — |
| S-1 | Registration statement | May 11, 2015 | — |
| S-8 | Employee stock plan registration | Jul 19, 2012 | — |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CSBR (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- DE
- Headquarters
- Baltimore, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 771856
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC. (until Mar 30, 2011); CHAMPIONS SPORTS INC (until Feb 16, 2007)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.